Fig. 3From: Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastasesComparison of recurrence-free survival (RFS) and overall survival (OS) after curative liver resection for patients who received neoadjuvant therapy stratified by response to NAC. a, Comparison of RFS in the low and high TBS groups among patients with partial response (PR). b, Comparison of OS in the low and high TBS groups among patients with PR. c, Comparison of RFS in the low and high TBS groups among patients with stable disease (SD) or progressive disease (PD). d, Comparison of OS in the low and high TBS groups among patients with SD or PDBack to article page